Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the Affera Ventricular Arrhythmia Ablation (AVAAR) Registry.
Open Access CRIS of the University of Bern · 01.09.2025
DOI: 10.48620/89069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access CRIS of the University of Bern, erschienen am 01.09.2025. Verfasst von Frédéric Sacher und 40 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The feasibility and safety of the lattice-tip catheter for ventricular arrhythmia (VA) ablation in humans remain largely unknown. This study aimed to assess feasibility, safety profile as well as patient outcomes after VA ablation with a lattice-tip catheter in a multicenter European registry.
Methods
All 18 European centers using the AFFERA system on September 2024 agreed to participate. Clinical, procedural, and follow-up data (minimum 3 months) were systematically collected and analyzed.
Results
A total of 126 patients (18% female; mean age 59 ±16 years) underwent VA ablation using the lattice-tip catheter during the inclusion period. Ablation indications included ventricular tachycardia (VT) in 99, premature ventricular complexes (PVCs) in 23, and ventricular fibrillation (VF) in 4 patients.Major and minor acute complications were observed in 7 (6%) and 18 (14%) procedures, respectively. They included thrombo-embolic event (n=2), major bleeding (n=2), ventricular fibrillation induction (n=1), tamponade due to epicardial access (n=1), cardiogenic shock due to prolonged VT mapping (n=1). Within the first month post-procedure, 3 patients died (from multi-organ failure (n=2) and sepsis (n=1)), 2 had worsening heart failure, 1 myocardial infarction, 1 sepsis and 1 major gastro-intestinal bleeding. After a mean follow-up of 5.6 ±3.7 months, absence of recurrence was 78% for PVC, 70% for VT, and 100% for VF.
Conclusion
In this complex population with refractory VA, ablation using the lattice-tip catheter appears feasible and relatively safe. In the absence of large, randomized trials, exhaustive registry is of key importance to ensure safety and efficacy of new catheter technologies.
Schlagwörter
Zitieren
APA
Sacher, F., Sarkozy, A., Pürerfellner, Helmut, Steyer, Alexandra, Lyne, Jonathan, Coquard, C., Tixier, R., Combes, N., Haı̈ssaguerre, M., Efremidis, Michalis, Duchâteau, J., Urda, Castro, V., Martin, A, C., …, & Peichl, P. (2025). Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the Affera Ventricular Arrhythmia Ablation (AVAAR) Registry. Open Access CRIS of the University of Bern. https://doi.org/10.48620/89069
Vancouver
Sacher F, Sarkozy A, Pürerfellner, Helmut, Steyer, Alexandra, et al. Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the Affera Ventricular Arrhythmia Ablation (AVAAR) Registry. Open Access CRIS of the University of Bern. 2025. doi:10.48620/89069
BibTeX
@article{Sacher2025,
author = {Sacher, Frédéric and Sarkozy, Andrea and Pürerfellner and Helmut and Steyer and Alexandra and Lyne and Jonathan and Coquard, Charlène and Tixier, Romain and Combes, Nicolas and Haı̈ssaguerre, Michel and Efremidis and Michalis and Duchâteau, Josselin and Urda and Castro, Victor and Martin and A, Claire and Lemoine, Marc Daniel and Bergaz, Alejandro Carta and Bogun, Frank Matthias and Linton and Nick and Derval, Nicolas and Schlosser, Filip and Pambrun, Thomas and Petru and Jan and Hocini, Mélèze and Pannone, Luigi and Mudroch and Martin and Kautzner and Josef and Jaı̈s, Pierre and Reichlin and Tobias and Neužil and Petr and Peichl, Petr},
title = {Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the Affera Ventricular Arrhythmia Ablation (AVAAR) Registry},
journal = {Open Access CRIS of the University of Bern},
year = {2025},
doi = {10.48620/89069}
}
EUVIMED